Press Release: PledPharma : PledPharma presents PledOx®'s phase III program at the Gastrointestinal (GI) Cancers Symposium

PledPharma AB (publ) announces that the company’s global phase III program, POLAR, has been accepted for a poster presentation during the Gastrointestinal (GI) Cancers Symposium in January 17-19 in San Francisco. The symposium is one of the most prominent within the field of gastrointestinal